Abstract
A randomized, controlled, clinical trial of etoricoxib in the treatment of rheumatoid arthritis.
Alan K Matsumoto, Agustin Melian, David R Mandel, Harris H McIlwain, David Borenstein, Peng Liang Zhao, Christopher R Lines, Barry J Gertz, Sean Curtis and Etoricoxib Rheumatoid Arthritis Study Group
The Journal of Rheumatology August 2002, 29 (8) 1623-1630;
Alan K Matsumoto
Agustin Melian
David R Mandel
Harris H McIlwain
David Borenstein
Peng Liang Zhao
Christopher R Lines
Barry J Gertz
In this issue
A randomized, controlled, clinical trial of etoricoxib in the treatment of rheumatoid arthritis.
Alan K Matsumoto, Agustin Melian, David R Mandel, Harris H McIlwain, David Borenstein, Peng Liang Zhao, Christopher R Lines, Barry J Gertz, Sean Curtis, Etoricoxib Rheumatoid Arthritis Study Group
The Journal of Rheumatology Aug 2002, 29 (8) 1623-1630;
A randomized, controlled, clinical trial of etoricoxib in the treatment of rheumatoid arthritis.
Alan K Matsumoto, Agustin Melian, David R Mandel, Harris H McIlwain, David Borenstein, Peng Liang Zhao, Christopher R Lines, Barry J Gertz, Sean Curtis, Etoricoxib Rheumatoid Arthritis Study Group
The Journal of Rheumatology Aug 2002, 29 (8) 1623-1630;